(Q43551354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

1 reference

Carolyn Bolden-Watson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

5

R B Lipton

1 reference

5 November 2019

L Newman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L K Mannix

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Landy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Silberstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D G Putnam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Jöbsis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Batenhorst

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S O'Quinn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

248-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

A population-based analysis of the diagnostic criteria of the International Headache Society.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Prevalence of frequent headache in a population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Estrogens, progestins, and headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

"Menstrual" migraine: towards a definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Menstrual migraine. Methods of prevention and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Preventive treatment of migraine: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Naratriptan: biological profile in animal models relevant to migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.111006248.X

10.1046/J.1526-4610.2001.111006248.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11264684%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference